Integrins and extracellular matrix: a novel mechanism of multidrug resistance

References

• Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 89, 1845–1853 (1997).
   PubMed Web of Science ®Google Scholar
• Obara K, Ghazizadeh M, Shimizu H et al Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma. Int. Oncol. 20, 255–260 (2002).
   PubMedGoogle Scholar
• Kudoh K, Takano M, Koshikawa T et al Comparative genomic hybridization for analysis of chromosomal changes in cisplatin-resistant ovarian cancer. Hum. Cell 13, 109–116 (2000).
   PubMedGoogle Scholar
• Struski S, Doco-Fenzy M, Trussardi A et al Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization. Genes Chmmasomes Cancer30, 136–142 (2001).
   PubMedGoogle Scholar
• Koyama H, Ayusawa D, Okawa M, Takatsuki A, Tamura G. Tunicamycin-resistant mutations in mouse FM3A cells. Mutat. Res. 96, 243–258 (1982).
   Google Scholar
• Palyi I, Bence J, SzikLa K, Hullan L. Dominance of resistance to the alkylating agent 1,2:5,6- dianhydrogalactitol in P388 mouse lymphoma hybrid cells. Cancer Chemother. Pharmacol 23, 41–46 (1989).
   Google Scholar
• Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitra cross-resistance, radioautographic and cytogenetic studies. Cancer Res. 30, 1174–1184 (1970).
   PubMed Web of Science ®Google Scholar
• Kartner N, Riordan JR, Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, 1285–1288 (1983).
   Google Scholar
• Roninson TB, Chin JE, Choi KG et al Isolation of human mdr DNA sequences amplified in multi-drug resistant KB carcinoma cells. Proc. Natl Acad. Sri. USA 83, 4538–4542 (1986).
   PubMed Web of Science ®Google Scholar
• Cole SP, Bhardwaj G, Gerlach JH et al Overexpression of a transporter gene in a multi-drug resistant human lung cancer cell line. Science 258, 1650–1654 (1992). iiGerlach JH, Endicott JA, Juranka PP et al Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multi-drug resistance. Nature 324, 485–489 (1986).
   Google Scholar
• Molecular Aspects of Medicine. Schustik C, Dalton WS (Ed.) Elsevier Science, London, UK (1995).
   Google Scholar
• Dalton WS, Grogan TM, Rybski JA et al Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation. Blood 73, 747–752 (1989).
   PubMed Web of Science ®Google Scholar
• Jiang EZ, Chang YJ, Lee JW et al Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome. Korean Med. Li 13, 617–622 (1998).
   Google Scholar
• Webb M, Brun M, McNiven M, Le Couteur D, Craft P. MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders. BE .thematol. 102, 710–717 (1998).
   Google Scholar
• Tada Y, Wada M, Migita T et al Increased expression of multi-drug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin. Int. j Cancer98, 630–635 (2002).
   PubMed Web of Science ®Google Scholar
• Takamura Y, Miyoshi Y, Taguchi T, Noguchi S. Prediction of chemotherapeutic response by Technetium 99m-MIBI scintigraphy in breast carcinoma patients. Cancer 92, 232–239 (2001).
   PubMedGoogle Scholar
• Faneyte IF, Kristel PM, van de Vijver MJ. Determining MDR1/P-glycoprotein expression in breast cancer. int. j Cancer 93, 114–122 (2001).
   Google Scholar
• Sinicrope FA, Hart J, Brasitus TA et al Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy and disease relapse. Cancer 74, 2908–2917 (1994).
   PubMed Web of Science ®Google Scholar
• Lai SL, Goldstein LJ, Gottesman MM et al MDR1 gene expression in lung cancer. Natl Cancer Inst. 81, 1144–1150 (1989).
   Google Scholar
• Duensing TD, Slate DL. Intracellular expression of P-glycoprotein in a human colon tumor cell line. Anticancer Res. 14, 13–19 (1994).
   PubMedGoogle Scholar
• Doyle LA, Yang W, Abruzzo LV et al A multi-drug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl Acad. Sri. USA 95, 15665–15670 (1998).
   Google Scholar
• Lage H, Dietel M. Effect of the breast- cancer resistance protein on atypical multi-drug resistance. Lancet Oncol 1, 169–175 (2000).
   PubMedGoogle Scholar
• Volk EL, Rohde K, Rhee M et al Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Res. 60, 3514–3521 (2000).
   PubMed Web of Science ®Google Scholar
• Faneyte IF, Kristel PM, Maliepaard M et al Expression of the breast cancer resistance protein in breast cancer. Clin. Cancer Res. 8, 1068–1074 (2002).
   PubMed Web of Science ®Google Scholar
• Scheffer GL, Maliepaard M, Pijnenborg AC et al Breast cancer resistance protein is localized at the plasma membrane in mitoxant. Cancer Res. 60, 2589–2593 (2000).
   PubMed Web of Science ®Google Scholar
• Ross DD, Yang W, Abruzzo LV et al Atypical multi-drug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. .1. Natl. Cancer Inst. 91, 429–433 (1999).
   Google Scholar
• Scheffer GL, Wijngaard PL, Hens MJ et al The drug resistance-related protein LRP is the human major vault protein. Nature Merl 1, 578–582 (1995).
   PubMed Web of Science ®Google Scholar
• Berger W, Elbling L, Micksche M. Expression of the major vault protein LRP in human non-small cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int. j Cancer 88, 293–300 (2000).
   Google Scholar
• VC:11M M, Mattem J, Koomagi R. Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance. Anticancer Drug 8, 931–936 (1997).
   Google Scholar
• List AF, Spier CS, Grogan TM et al Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 87, 2464–2469 (1996).
   PubMed Web of Science ®Google Scholar
• Van Brussel JP, Jan Van Steenbrugge, Van Krimpen C et al Expression of multi-drug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer.' Uml. 165, 130–135 (2001).
   Google Scholar
• Arts HJ, Katsaros D, de Vries EG et al Drug resistance-associated markers P—glycoprotein, multi-drug resistance-associated protein 1, multi-drug resistance-associated protein 2 and lung resistance protein as prognostic factors in ovarian carcinoma. Clin. Cancer Res. 5, 2798–2805 (1999).
   Google Scholar
• Hall AG. Glutathione and the regulation of cell death. Adv. Exp. Med. Biol. 457, 199–203 (1999).
   PubMedGoogle Scholar
• Salinas AE, Wong MG. Glutathione S- transferases — a review. Cum Med. Chem. 6, 279–309 (1999).
   PubMed Web of Science ®Google Scholar
• Goto S, Ihara Y, Urata Y et al Doxorubicin- induced DNA intercalation and scavenging by nuclear glutathione S-transferase it. FASEB 115,2702–2714 (2001).
   Google Scholar
• Perquin M, Oster T, Maul A et al The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. j Cancer Res. Oncol 127, 368–374 (2001).
   PubMed Web of Science ®Google Scholar
• Buser K, Joncourt F, Altermatt HJ et al Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Ann. Oncol. 8,335–341 (1997).
   PubMed Web of Science ®Google Scholar
• Redmond SM, Joncourt F, Buser K et al Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and 06-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res. 51, 2092–2097 (1991).
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Kawasaki M, Bai F et al. Expression of p53 and glutathione 5-transferase-n relates to clinical drug resistance in non-small cell lung cancer. Oncology57, 318–323 (1999).
   PubMed Web of Science ®Google Scholar
• Pratesi G, Dal Bo L, Paolicchi A et al. The role of the glutathione-dependent system in tumor sensitivity to cisplatin: a study of human tumor xenografts. Ann. Oncol 6, 283–289 (1995).
   PubMedGoogle Scholar
• Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49, 5870–5878 (1989).
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim. Biophys. Acta 1400, 195–211 (1998).
   PubMed Web of Science ®Google Scholar
• Koshiyama M, Fujii H, Kinezaki M et al Immunohistochemical expression of topoisomerase IIa (Topoand multi-drugresistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. Anticancer Res 21, 2925–2932 (2001).
   PubMedGoogle Scholar
• Nielsen D, Maare C, Eriksen J et al. Characterisation of multi-drug resistant Ehrlich ascites tumor cells selected in vivo for resistance to etoposide. Biochem. Pharmacol 60, 353–361 (2000).
   PubMed Web of Science ®Google Scholar
• I age H, Helmbach H, Dietel M, Schadendorf,D. Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance. Br. Cancer 82, 488–491 (2000).
   Google Scholar
• Kobayashi M, Adachi N, Aratani Y, Kikuchi A, Koyama H. Decreased topoisomerase IIa expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells. Cancer Lett. 166, 71–77 (2001).
   Google Scholar
• Matsumoto Y, Takano H, Nagao S, Fojo T Altered topoisomerase ha and multi-drug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure. Jpnj Cancer Res. 92, 968–974 (2001).
   Google Scholar
• Matsumoto Y, Takano H, Kunishio K, Nagao S, Fojo T Hypophosphorylation of topoisomerase Ha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation. Jpnj Cancer Res. 92, 799–805 (2001).
   Google Scholar
• de Jong S, Zifistra JG, de Vries EG, Mulder NH. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 50, 304–309 (1990).
   PubMed Web of Science ®Google Scholar
• Dingemans AC et al Topoisomerase ha and other drug resistance markers in advanced non-small cell lung cancer. Lung Cancer32, 117–128 (2001).
   Google Scholar
• Dingemans AM, Witlox MA, Stallaert RA et al Expression of DNA topoisomerase Hoc and topoisomerase III genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin. Cancer Res. 5, 2048–2058 (1999).
   PubMed Web of Science ®Google Scholar
• Zijlstra JG, de Vries EG, Mulder NH. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47, 1780–1784 (1987).
   PubMed Web of Science ®Google Scholar
• Lotem J, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor 01 and cancer chemotherapy compounds in myeloid leukemic cells. B/ooc/80, 1750–1757 (1992).
   Google Scholar
• Arlt A, Vorndamm J, Muerkoster S et al Autocrine production of interleukin- 113 confers constitutive nuclear factor -KB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res. 62, 910–916 (2002).
   PubMed Web of Science ®Google Scholar
• Lucero Gritti MF, Beviacqua M, Bordenave RII, Rumi LS. Interferon-a2b modulationof doxorubicin sensitivity in a multi-drug resistant cell line. I Exp. Clin. Cancer Res. 20, 393–400 (2001).
   Google Scholar
• Matarrese P, Di Biase L, Santodonato L et al Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function. AIR I Pathol 160, 1507–1520 (2002).
   PubMed Web of Science ®Google Scholar
• Raff MC. Social controls on cell survival and cell death. Nature 356, 397–400 (1992).
   PubMed Web of Science ®Google Scholar
• Teicher BA, Herman TS, Holden SA et al Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247, 1457–1461 (1990).
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Man S, Graham CH et al Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl Acad. Sci USA 90, 3294–3298 (1993).
   PubMed Web of Science ®Google Scholar
• Desoize B, Jardillier J. Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol 36, 193–207 (2000).
   PubMed Web of Science ®Google Scholar
• Oloumi A, MacPhail SH, Johnston PJ, Banath JP, Olive PL. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer Res. 60, 5747–5753 (2000).
   Google Scholar
• Desoize B, Gimonet D, Jardiller JC. Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res. 18, 4147–4158 (1998).
   PubMed Web of Science ®Google Scholar
• Hauser IA, Setter E, Bell L, Madri JA. Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro. Am. Pathol 143, 173–180 (1993).
   Google Scholar
• Carpizo D, Iruela-Arispe ML. Endogenous regulators of angiogenesis-emphasis on proteins with thrombospondin-type I motifs. Cancer Nktastasis Rev 19, 159–165 (2000).
   PubMedGoogle Scholar
• Brooks PC, Montgomery AM, Rosenfeld M et al Integrin avI33 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Ce1179, 1157–1164 (1994).
   Google Scholar
• Chenard M, Basque JR, Chailler P et al Expression of integrin subunits correlates with differentiation of epithelial cell lineages in developing human gastric mucosa. Anat. Embryo" (Ben) 202,223–233 (2000).
   Google Scholar
• Frisch SM, Screaton RA. Anoikis mechanisms. Curt: Opin. Cell Biol. 13, 555–562 (2001).
   Google Scholar
• Zhang Z, Vuori K, Reed JC, Ruoslahti E. The (x5131 integrin supports survival of cells on fibronectin and upregulates Bc1-2 expression. Proc. Natl Acad. Sci. USA 92, 6161–6165 (1995).
   Google Scholar
• Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. MalCe114, 953–961 (1993).
   Google Scholar
• Bates RC, Buret A, van Helden DF, Horton MA, Burns GE Apoptosis induced by inhibition of intercellular contact.j Cell Biol. 125,403–415 (1994).
   PubMed Web of Science ®Google Scholar
• Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis.j Cell Biol. 124,619–626 (1994).
   PubMed Web of Science ®Google Scholar
• Durand RE, Sutherland RM. Effects of intercellular contact on repair of radiation damage. Exp. Cell Res. 71,75–80 (1972).
   PubMed Web of Science ®Google Scholar
• •First demonstration of extracellular protection against DNA insult.
   Google Scholar
• Fridman R, Giaccone G, Kanemoto T et al. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc. Nall Acad. Sci. USA 87,6698–6702 (1990).
   PubMed Web of Science ®Google Scholar
• •In vitro small cell lung cancer cells protected from chemotherapy by adherence to laminin.
   Google Scholar
• Sethi T, Rintoul RC, Moore SM et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med. 5,662–668 (1999).
   PubMed Web of Science ®Google Scholar
• ••Chemoprotective effect of fibronectin,laminin and collagen mediated via Di integrin and tyrosine ldnase-dependent inhibition of apoptosis.
   Google Scholar
• Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blooc193, 1658–1667 (1999). First description of ECM-induced chemoprotection in hemopoietic cell lines. Bax-Bcl system not implicated in this cell line.
   Google Scholar
• Damiano JS, Dalton WS. Integrin- mediated drug resistance in multiple myeloma. Leuk. Lymphoma 38,71–81 (2000).
   PubMed Web of Science ®Google Scholar
• Hazlehurst LA, Valkov N, Wisner L et al Reduction in drug-induced DNA double-strand breaks associated with bet al integrin-mediated adhesion correlates with drug resistance in U937 cells. Blooc198, 1897–1903 (2001).
   Google Scholar
• •ECM-mediated chemoprotection of lymphoma cells is a result of reduced DNA damage due to altered distribution of topoisomerase II in the nucleus.
   Google Scholar
• Taylor ST, Hickman JA, Dive C. Epigenetic determinants of resistance to etoposide regulation of Bd.- X(L) and Bax by tumor microenvironmental factors. j Natl Cancer Inst. 92,18–23 (2000).
   Google Scholar
• •Lymphoma — demonstration of Di integrin-dependent upregulation of Bc1X(L) in a NM-dependent manner resulting in etoposide resistance.
   Google Scholar
• Taylor ST, Hickman JA, Dive C. Survival signals within the tumor microenvironment suppress drug- induced apoptosis: lessons learned from B-lymphomas. Endocr Relat. Cancer6, 21–23 (1999).
   Google Scholar
• Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs and gamma-irradiation. Leukemia 15,1232–1239 (2001).
   Google Scholar
• de la Fuente MT, Casanova B, Moyano JV et al Engagement of a4131 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. j Leukoc. Biol. 71,495-502 (2002).
   Google Scholar
• Narita T, Kimura N, Sato M, Matsuura N, Kannagi R. Altered expression of integrins in adriamycin-resistant human breast cancer cells. Anticancer Res. 18, 257–262 (1998).
   Google Scholar
• Nista A, Leonetti C, Bernardini G, Mattioni M, Santoni A. Functional role of (x4131 and (x5131 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int. j Cancer 72,133–141 (1997).
   Google Scholar
• •13 lintegrin-mediated binding to fibronectin causes G1—S progression preventing serum deprivation-induced apoptosis.
   Google Scholar
• Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 20,4995–5004 (2001).
   PubMed Web of Science ®Google Scholar
• •Integrin-mediated chemoprotection in breast cancer cells is phosphoinosito1-3-kinase and protein kinase B dependent in a mechanism which involves inhibition of cytochrome c release.
   Google Scholar
• Pogany G, Timar F, Olah J et al Role of the basement membrane in tumor cell dormancy and cytotoxic resistance. Oncology60,274–281 (2001).
   PubMedGoogle Scholar
• •ECM-mediated chemoprotection in breast, osteosarconaa and fibrosarconaa cancer cells.
   Google Scholar
• Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin. Cancer Res. 5,1587–1594 (1999).
   Google Scholar
• •ECM-mediated chemoprotection in malignant glioma cells.
   Google Scholar
• Kouniavsky G, Khaikin M, Zvibel I et al Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines. Clin. Exp. Metastasis 19, 55–60 (2002).
   PubMed Web of Science ®Google Scholar
• •ECM-mediated chemoprotection in colon cancer cells.
   Google Scholar
• Liang Y, Meleady P, Cleary I et al Selectionwith melphalan or paclitaxel (Taxo0 yields variants with different patterns of multi-drug resistance, integrin expression and in vitro invasiveness. Eur. Cancer37, 1041–1052 (2001).
   Google Scholar
• Duensing S, Brevis Nunez F et al Exposure to vinblastine modulates 131 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. Invasion Metastasis 16,65–72 (1996).
   PubMedGoogle Scholar
• Hikawa T, Mori T, Abe T, Hon i S. The ability in adhesion and invasion of drug-resistant human glioma cells. I Exp. Clin. Cancer Res. 19,357–362 (2000).
   PubMedGoogle Scholar
• Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. .1. Cell Sci.108 (Pt 3), 947–956 (1995).
   Google Scholar
• Sedlak J, Sedlakova O, Hlavcak P et al Cell surface phenotype and increased penetration of human multidrug- resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix. Neoplasma 43, 389–395 (1996).
   PubMedGoogle Scholar
• Maubant S, Cruet-Hennequart S, Poulain L et al Altered adhesion properties and av integrin expression in a cisplatin-resistant human ovarian carcinoma cell line. int. Cancer97, 186–194 (2002).
   PubMed Web of Science ®Google Scholar
• Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Gun. Cancer Res. 8,878-884 (2002).
   Google Scholar
• •Demonstration of resistance to drug penetration in multicellular layer that secretes ECM.
   Google Scholar
• Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jam RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60, 2497–2503 (2000).
   Google Scholar
• Baumgartner G, Gomar-Hoss C, Sakr L, Ulsperger E, Wogritsch C. The impact of extracellular matrix on the chemoresistance of solid tumors-experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy. Cancer Lett. 131, 85–99 (1998).
   PubMed Web of Science ®Google Scholar
• Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev 20, 43–50 (2001).
   PubMed Web of Science ®Google Scholar
• Hoyt DG, Rizzo M, Gerritsen ME, Pitt BR, Lazo JS. Integrin activation protects pulmonary endothelial cells from the genotoxic effects of bleomycin. Am. Physio1273, L612—L617 (1997).
   Google Scholar
• •Reduction in bleomycin-induced DNA damage in the presence of ECM proteins.
   Google Scholar
• Jones CB, McIntosh J, Huang H, Graytock A, Hoyt DG. Regulation of bleomycin-induced DNA breakage and chromatin structure in lung endothelial cells by integrins and poly(ADP-ribose) polymerase. Mal Pharmacol 59,69–75 (2001).
   Google Scholar
• van Riet I, de Greef C, del Favero H, Demanet C, Van Camp B. Production of fibronectin and adherence to fibronectin by human myeloma cell lines. BE j .thematol. 87,258–265 (1994).
   PubMed Web of Science ®Google Scholar
• Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins and immunoglobulin-superfamily members. Ann. Rev Pharmacol Toxicol 42, 283–323 (2002).
   PubMed Web of Science ®Google Scholar
• Coppolino MG, Dedhar S. Bi-directional signal transduction by integrin receptors. Int. Biochem. Cell Biol. 32,171–188 (2000).
   PubMedGoogle Scholar
• Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 14,381–395 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signaling spreads. Nature Cell Biol. 4, E65—E68 (2002).
   Google Scholar
• Schaller MD. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540,1–21 (2001).
   PubMed Web of Science ®Google Scholar
• Jones RJ, Brunton VG, Frame MC. Adhesion-linked kinases in cancer; emphasis on sic, focal adhesion kinase and PI 3-kinase. Eur. Cancer36, 1595–1606 (2000).
   Google Scholar
• Jones JL, Walker RA. Integrins: a role as cell signaling molecules. Mal Pathol 52,208–213 (1999).
   PubMedGoogle Scholar
• Hughes PE, Renshaw MW, Pfaff M et al Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAPK pathway. Ce1188, 521–530 (1997).
   Google Scholar
• Takagi J, Erickson HP, Springer TA. C-terminal opening mimics 'inside-out' activation of integrin oc5 1. Nature Struct. Biol. 8,412-416 (2001). iii Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. j Cell Biol. 155,505-510 (2001).
   Google Scholar
• Parise LV, Lee J, Juliano RL. New aspects of integrin signaling in cancer. Sernin. Cancer Biol. 10,407–414 (2000).
   PubMedGoogle Scholar
• O'Neill GM, Fashena SJ, Golemis EA. Integrin signaling: a new Cas(t) of characters enters the stage. Trends Cell Biol. 10,111–119 (2000).
   PubMedGoogle Scholar
• Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. j Cell Biol. 155, 459–470 (2001).
   Google Scholar
• Rintoul RC, Sethi T Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin. Sci. 102,417–424 (2002).
   PubMed Web of Science ®Google Scholar
• Ng SSW Tsao MS, Chow S, Hedley DW. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res. 60,5451–5455 (2000).
   PubMedGoogle Scholar
• Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB. Inhibition of phosphatidylinositol kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res. 62,1087–1092 (2002).
   Google Scholar
• Inoue S, Salah-Eldin AE, Omoteyama K. Apoptosis and anticancer drug resistance. Hum. Ce1114, 211–221 (2001).
   Google Scholar
• Heere-Ress E, Thallinger C, Lucas T et al. Bc1-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. int. Cancer99, 29–34 (2002).
   Google Scholar
• Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-dependent kinases Oa cytoplasmic signaling pathways. Cell Sci 114,2553–2560 (2001).
   PubMed Web of Science ®Google Scholar
• Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2 and phosphorylation of the retinoblastoma protein.j Cell Biol. 133,391-403 (1996).
   Google Scholar
• Cambier S, Mu DZ, O'Connell D et al. A role for the integrin avI38 in the negative regulation of epithelial cell growth. Cancer Res. 60,7084-7093 (2000).
   Google Scholar
• Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS. Adhesion to fibronectin via 01 integrins regulates p27kipl levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene 19,4319–4327 (2000).
   Google Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix met alloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387–2392 (2002).
   PubMed Web of Science ®Google Scholar